Intra-Cellular Therapies, Inc.
NOVEL COMPOUNDS
Last updated:
Abstract:
The present disclosure relates to novel PDE2 inhibitory compounds of Formula I as described herein, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Status:
Application
Type:
Utility
Filling date:
23 Oct 2019
Issue date:
3 Mar 2022